Treatment Dilemmas: ECT for Depressed Teens
Psychopharmacology and Psychiatry Updates
Release Date: 10/28/2024
Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial
Psychopharmacology and Psychiatry Updates
In this episode, we explore the RADAR trial's findings on antipsychotic dose reduction in schizophrenia. Can patients with chronic schizophrenia safely reduce or discontinue their antipsychotic medications without increasing relapse risk? The trial's results challenge common assumptions about medication reduction and provide crucial guidance for clinical practice. Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.
info_outline
Unraveling Agitation: Mania vs. Substance Use
Psychopharmacology and Psychiatry Updates
In this episode, we explore the challenges of diagnosing and managing agitation in emergency settings, focusing on mood disorders and substance use. Dr. Scott Zeller shares insights on differentiating acute mania from substance-induced psychosis. How can clinicians navigate the complex interplay between psychiatric symptoms and substance effects in emergencies? Faculty: Scott Zeller, M.D. Host: Richard Seeber, M.D.
info_outline
Pushing the Boundaries: Exploring High-Dose Antipsychotics
Psychopharmacology and Psychiatry Updates
In this episode, we explore the use of high-dose olanzapine as a potential alternative to clozapine for treatment-resistant schizophrenia. We discuss a systematic review that examines the efficacy and safety of olanzapine doses above the FDA-approved maximum. Could high-dose olanzapine be a viable option when patients refuse clozapine? Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.
info_outline
The Psychodynamic Prescriber
Psychopharmacology and Psychiatry Updates
In this episode, we explore how integrating psychodynamic principles into pharmacotherapy can enhance treatment outcomes. We discuss seven key features of psychodynamic psychotherapy and their application in routine psychiatric practice. How might understanding a patient's fantasies about their illness impact their response to medication? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.
info_outline
From Inpatient to Outpatient: Initiating Benzodiazepine Tapering
Psychopharmacology and Psychiatry Updates
In this episode, we explore strategies for discontinuing benzodiazepines in hospitalized elderly patients. We discuss a recent Israeli study that tested two interventions during inpatient stays. Can a simple hospital-based intervention lead to successful long-term medication changes? Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D.
info_outline
The Power of Alliance in Psychopharmacology
Psychopharmacology and Psychiatry Updates
In this episode, we explore the critical role of therapeutic alliance in psychopharmacology. We discuss how factors like empathy, communication, and shared decision-making can significantly impact treatment outcomes. Did you know that a doctor's warm voice can increase appointment adherence by 162%? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.
info_outline
Antipsychotics in Youth: Balancing Metabolic Risk
Psychopharmacology and Psychiatry Updates
In this episode, we explore the cardiac and metabolic safety profile of antipsychotics in youth, based on a World Health Organization Safety Database analysis. We discuss age-dependent risks, specific medication concerns, and the importance of monitoring. How can clinicians balance the benefits of antipsychotics with potential cardiometabolic risks in young patients? Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.
info_outline
The Double-Edged Sword of Biological Explanations in Mental Health
Psychopharmacology and Psychiatry Updates
In this episode, we explore the unexpected consequences of promoting a purely biological view of mental illness. How does framing mental health conditions as solely biological affect stigma, patient outcomes, and physician empathy? We delve into the complex interplay between biological and psychosocial factors in mental health treatment. Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.
info_outline
New Insights into Psychiatric and Cardiovascular Comorbidity
Psychopharmacology and Psychiatry Updates
In this episode, we explore the bidirectional relationship between psychiatric disorders and cardiovascular disease, discussing a groundbreaking study involving over 900,000 subjects. We ask: Can a mental health diagnosis increase your risk of heart disease? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D.
info_outline
Beyond the Pill: The Psychology of Psychopharmacology
Psychopharmacology and Psychiatry Updates
In this episode, we explore the science behind the art of psychopharmacotherapy with Dr. David Mintz. We delve into how psychosocial factors, including the prescriber's approach, can significantly impact medication outcomes. Did you know that some psychiatrists achieve better results with placebos than others do with active medications? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D.
info_outlineIn this episode, we explore the controversial use of electroconvulsive therapy (ECT) in adolescents with severe depression and suicidality. We discuss a study examining ECT's effectiveness, factors influencing outcomes, and its potential as a treatment option. Is ECT a viable last resort for treatment-resistant depression in teens?
Faculty: David Rosenberg, M.D.
Host: Richard Seeber, M.D.